Počet záznamov: 1
Can we influence manifestation of metabolic syndrome by using antipsychotic drugs in patients with schizophrenia?
SYS 0062530 LBL 00000naa--2200000-a-4500 005 20250607140506.0 008 110503c2007----xo-----e------------eng-- 040 $a BA006 $b slo 041 0-
$a eng 044 $a xo $c SK 245 10
$a Can we influence manifestation of metabolic syndrome by using antipsychotic drugs in patients with schizophrenia? / $c Vachulova A. ... [et al.] 300 $b ilustr., tab. 500 $a European heart journal, vol. 28, suppl. 1 (2008), s. 347 700 1-
$7 sllk_us_auth*p0040887 $a Vachulová, Anna $u 2. interná klinika LFUK a FNsP, Bratislava $4 aut 700 1-
$7 sllk_us_auth*0001325 $a Bukovinová, Pavlína $u Klinika infektológie a geografickej medicíny LF UK, Bratislava $4 aut 700 1-
$7 sllk_us_auth*p0041597 $a Penz, Peter $u FNsP, Bratislava $4 aut 700 1-
$7 sllk_us_auth*p0055150 $a Janoška, Dalibor $u Psychiatrická nemocnica Ph. Pinela, Pezinok $4 aut 700 1-
$7 sllk_us_auth*p0040888 $a Vohnout, Branislav $u II. interná klinika LFUK a FNsP, Bratislava $4 aut 711 2-
$7 sllk_us_auth*0018073 $a European Society of Cardiology (ESC) $d (2007 : $c Vienna, Austria) $e Congress 773 0-
$7 nnas $w sllk_us_cat*0012343 $t Kardiológia. Program, súhrny a zborník abstraktov XII. kongres Slovenskej kardiologickej spoločnosti : Bratislava, 4. -6. október 2007 $x 1210-0048 $d Bratislava : SymeKard $g Vol. 16, suppl. 1 (2007), s. 56S
Počet záznamov: 1